HMS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-700
Closed -$326K 162
2020
Q4
$326K Sell
700
-1,500
-68% -$703K 0.15% 111
2020
Q3
$971K Hold
2,200
0.38% 49
2020
Q2
$796K Buy
+2,200
New +$737K 0.35% 63
2020
Q1
Sell
-2,100
Closed -$682K 155
2019
Q4
$682K Hold
2,100
0.29% 86
2019
Q3
$612K Hold
2,100
0.23% 111
2019
Q2
$616K Sell
2,100
-600
-22% -$165K 0.27% 93
2019
Q1
$739K Buy
2,700
+900
+50% +$224K 0.31% 83
2018
Q4
$403K Buy
+1,800
New +$422K 0.2% 122

Other funds holding TMO

HMS Capital Management's TMO Position: Q1 2024 in Review

HMS Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 1,546 shares — an estimated $821K sold.

HMS Capital Management first reported a position in TMO in Q4 2018 and held it in 21 quarters. The position peaked at $3.79M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • HMS Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • HMS Capital Management sold 1,546 Thermo Fisher Scientific shares in Q1 2024, an estimated $821K.
  • HMS Capital Management first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 21 quarters.
  • HMS Capital Management's Thermo Fisher Scientific position peaked at $3.79M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on HMS Capital Management's 13F filing for Q1 2024, filed 24 Apr 2024.